Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EyeScience develops new eye vitamin for diabetes patients
The new product called Diabetic Vision Formula was developed to help protect against potential vision problems associated with diabetic retinopathy, a condition that may lead to blindness and
The new product called Diabetic Vision Formula was developed to help protect against potential vision problems associated with diabetic retinopathy, a condition that may lead to blindness and
The application was not approved by FDA because the pre-specified analysis of the primary endpoint in the study (DACO-016) did not demonstrate statistically significant superiority of Dacogen over
CK-2017357, the lead drug candidate that has emerged from the Cytokinetics’ skeletal sarcomere activator program, is currently the subject of an ongoing Phase II clinical development program in
The prospectively designed, head-to-head clinical trials will provide important information to physicians, patients, caregivers, and payors to make informed choices, said the company. Shire Specialty Pharmaceuticals and Regenerative
As per the agreement, the companies aim to develop and commercialize at least three new vaccines with MTPC who will provide funding for all research and development costs.
Stealth decided to move forward with Unigene’s platform following the data of an oral feasibility study for its pipeline candidate using the latter’s oral delivery technology relative to
This open-label Phase II study will evaluate the efficacy, pharmacodynamics, safety and tolerability of oral BL-7040 in up to 20 patients with moderately active ulcerative colitis, a type
The additional space will be used to the build a second GMP manufacturing clean room suite and space for team members. BioLife Solutions chief executive officer Mike Rice
The investment sees the company expand its containment facilities with a 15,000sq ft new development and commercial manufacturing unit for tablets and capsules. The new facility will enable
Medicyte is a company involved in the generation of human primary cells based on the upcyte technology, while Primacyt is a firm involved in long-term culturing of primary